抗体药-话题@MedSci - 梅斯（MedSci）

#抗体药#

67篇内容 | 2273人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1957596, encodeId=218c195e596b3, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=Blend再获2100万美元投资助力抗体药物偶联疗法研发, objectType=article, longId=45244, objectId=2b39452449b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b39452449b, replyNumber=0, likeNumber=106, createdTime=2015-05-23, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b39452449b, moduleTitle=Blend再获2100万美元投资助力抗体药物偶联疗法研发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b39452449b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957593, encodeId=e7ec195e593cc, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=复宏汉霖获得单克隆抗体药物临床批件, objectType=article, longId=32937, objectId=8e9b3293eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e9b3293eeb, replyNumber=0, likeNumber=94, createdTime=2014-07-06, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e9b3293eeb, moduleTitle=复宏汉霖获得单克隆抗体药物临床批件, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e9b3293eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957592, encodeId=79c5195e592da, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=ImmunoGen放弃其抗体药物IMGN901二期研究, objectType=article, longId=26348, objectId=9fc92634877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fc92634877, replyNumber=0, likeNumber=66, createdTime=2013-12-26, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fc92634877, moduleTitle=ImmunoGen放弃其抗体药物IMGN901二期研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9fc92634877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957591, encodeId=0ec5195e591d2, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=Nature：抗体药物将重振偏头痛药物的开发, objectType=article, longId=17723, objectId=34091e7237a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34091e7237a, replyNumber=0, likeNumber=67, createdTime=2014-02-07, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34091e7237a, moduleTitle=Nature：抗体药物将重振偏头痛药物的开发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=34091e7237a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957589, encodeId=2446195e58901, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=J. Neurosci.：动物模型新研究表明Tau抗体药物有助于治疗阿尔茨海默病, objectType=article, longId=8301, objectId=5cc983010e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cc983010e, replyNumber=0, likeNumber=69, createdTime=2012-09-09, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cc983010e, moduleTitle=J. Neurosci.：动物模型新研究表明Tau抗体药物有助于治疗阿尔茨海默病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5cc983010e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957590, encodeId=f3fb195e590f0, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=[AAIC 2012]tau抗体药物EpoD有助防治阿尔茨海默病, objectType=article, longId=8370, objectId=7afd83e0e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7afd83e0e8, replyNumber=0, likeNumber=83, createdTime=2013-06-26, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7afd83e0e8, moduleTitle=[AAIC 2012]tau抗体药物EpoD有助防治阿尔茨海默病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7afd83e0e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957588, encodeId=4cc0195e588e6, content=<a href='/topic/show?id=a09c551998a' target=_blank style='color:#2F92EE;'>#抗体药#</a>, objectTitle=安进（Amgen）实验性抗体药物AMG145 Ib期研究取得惊人数据, objectType=article, longId=5392, objectId=34ee5392fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ee5392fc, replyNumber=0, likeNumber=100, createdTime=2012-11-14, rootId=0, userName=12498e5fm12(暂无昵称), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ee5392fc, moduleTitle=安进（Amgen）实验性抗体药物AMG145 Ib期研究取得惊人数据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=34ee5392fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗体药

2020-05-29

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

Blend再获2100万美元投资助力抗体药物偶联疗法研发

2015-05-23

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

复宏汉霖获得单克隆抗体药物临床批件

2014-07-06

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

ImmunoGen放弃其抗体药物IMGN901二期研究

2013-12-26

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

Nature：抗体药物将重振偏头痛药物的开发

2014-02-07

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

J. Neurosci.：动物模型新研究表明Tau抗体药物有助于治疗阿尔茨海默病

2012-09-09

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

[AAIC 2012]tau抗体药物EpoD有助防治阿尔茨海默病

2013-06-26

12498e5fm12(暂无昵称) (审核中...)

前往app查看评论内容

#抗体药#

安进（Amgen）实验性抗体药物AMG145 Ib期研究取得惊人数据

2012-11-14

科室
- - 订阅+
  - 更多科室
工具
服务